New research suggests that individuals who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who stop conventional lifestyle regimens.
Published data in a major medical journal shows that while obese individuals can lose a large proportion of their body weight while on the medication, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals buying such medications must be informed of the risk of quick weight regain when the therapy ends," warns expert Dr. Susan Jebb.
That rate of recovery means a return to starting mass in about a year and a half.
Analyzing Therapies
The research, which examined dozens of trials involving thousands of patients, compared the effects of the injectable medications with conventional dieting.
Scientists emphasize that individuals who lose weight through diet and exercise typically experience a slower creep back—approximately 100 grams monthly—once they finish.
Explaining the Fast Rebound
Doctors suggest the mechanism of the jabs explains the heightened rebound.
GLP-1 drugs copy a body's own chemical called GLP-1, which moderates hunger.
"Sustained high doses of GLP-1 levels several times higher than normal could lead to the body to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' leads to appetite is uncontrolled, making overeating much more probable."
A Chronic Disease?
The NHS suggest the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
Many experts say that, due to the high risk of weight regain, the therapy should be considered long-term.
This perspective is reinforced by pharmaceutical companies, who note that the results "emphasize the chronic character of obesity," comparing it to managing diseases like high blood pressure.
User Accounts
Individuals who have stopped the medication explain a powerful return of cravings.
"I experienced a trigger flipping and you become extremely hungry," described an individual.
This challenge is compounded if individuals have not established permanent lifestyle or habit changes during treatment.
Widespread Interest
Figures show that a significant number of adults in the UK have used these injections in the past year, with demand remaining high.
- Adoption is greater among women than males.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
Ultimately, clinicians emphasize that while GLP-1 drugs are powerful tools for weight loss, they are not a magic solution and lasting health benefits likely depends on integrated behavioural changes.
